Education
About Us
Working with TipRanks
Follow Us
Gelteq Limited (GELS)
:GELS
GELS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.95 - $5.50
Previous CloseN/A
Volume20.79K
Average Volume (3M)22.36K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)1.42M
Price to Earnings (P/E)―
Beta2.35
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding9,438,075
10 Day Avg. Volume25,294
30 Day Avg. Volume22,357
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Gelteq Limited News
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
0.54% Other Institutional Investors
99.46% Public Companies and
Individual Investors
GELS FAQ
What was Gelteq Limited’s price range in the past 12 months?
Gelteq Limited lowest stock price was $0.95 and its highest was $5.50 in the past 12 months.
What is Gelteq Limited’s market cap?
Currently, no data Available
When is Gelteq Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Gelteq Limited’s earnings last quarter?
Currently, no data Available
Is Gelteq Limited overvalued?
According to Wall Street analysts Gelteq Limited’s price is currently Overvalued.
Does Gelteq Limited pay dividends?
Gelteq Limited does not currently pay dividends.
What is Gelteq Limited’s EPS estimate?
Gelteq Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Gelteq Limited have?
Gelteq Limited has 9,438,075 shares outstanding.
What happened to Gelteq Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Gelteq Limited?
Currently, no hedge funds are holding shares in GELS
---
Company Description
Gelteq Limited
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.
---
Technical Analysis
Amgen
―
BioMarin Pharmaceutical
―
Gilead Sciences
―
Regeneron
―
Vertex Pharmaceuticals
―
---